We sell in-depth short-selling reports for any company ₿ 1 BTC.
Contact us today.
Short Interest Update USOVID

OVID Short Interest Plummets as Shorts Retreat

OVID is seeing a rapid unwind of short positions ahead of its November 13 earnings print, with short interest dropping 33% over the past month.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk November 10, 20261 min read
Company
Ovid Therapeutics
Borrow Fee
0.70%
Short % Float
23.2%
Days to Cover
1.5

OVID enters its November 13 earnings print on the back of a sharp short squeeze in the lending market. The clearest shift in positioning is the rapid unwind of short interest. OVID's SI % of free float stands at 23.2%, still high in absolute terms, but the number has fallen roughly 33% over the past month, dropping from more than 26 million shares shorted in late September to around 16.5 million today. This substantial cover coincides with the stock's 19% weekly gain. Borrow conditions are loose and getting looser: availability has expanded to 227%, well above the 52-week tightest level of 43%, meaning supply of shares to lend has grown substantially relative to what is already borrowed. Cost to borrow remains negligible at 0.70%, confirming that the retreat in short positions is driven by conviction rather than a forced squeeze.

Source

Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#OVID#Short Interest#Earnings

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets. Costs: ₿ 1 BTC

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog
Contact Us on Telegram